Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Innovation Limited
Symbol
CNTB
Shares outstanding
55,577,689 shares
Disclosed Ownership
13,950,000 shares
Ownership
25%
Form type
SCHEDULE 13D/A
Filing time
21 Jul 2025, 09:00:04 UTC
Date of event
21 Jul 2025

Sponsored

Quoteable Key Fact

"Panacea Innovation Ltd disclosed 25% ownership in Connect Biopharma Holdings Limited Ordinary Shares (CNTB) on 21 Jul 2025."

Quick Takeaways

  • Panacea Innovation Ltd filed SCHEDULE 13D/A for Connect Biopharma Holdings Limited Ordinary Shares (CNTB).
  • Disclosed ownership: 25%.
  • Date of event: 21 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 21 Jul 2025, 09:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Innovation Limited 25% 13,950,000 0 13,950,000 /s/ James Huang James Huang, Founding Managing Partner 0002010692
Panacea Venture Healthcare Fund II, L.P. 25% 13,950,000 0 13,950,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner 0001869939
Panacea Venture Healthcare Fund II GP Company, Ltd. 25% 13,950,000 0 13,950,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
James Huang 25% 13,950,000 0 13,950,000 /s/ James Huang James Huang 0001573160